Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-22

Clinical Trial Update: Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study.

View source ↗

Summary

Update on the Imperial Prostate 6 study, a cancer histology AI reliability trial sponsored by Imperial College London, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Imperial College London | Conditions: Prostatic Neoplasms | Status: ACTIVE_NOT_RECRUITING